Back to News
Market Impact: 0.25
Milestone Pharmaceuticals Inc. Receives Nasdaq Notice of Non-Compliance Under Rule 5450(a)(1)
Source: Nasdaq
Regulation & LegislationCompany Fundamentals
On October 23, 2026, Milestone Pharmaceuticals received notice from Nasdaq’s Listing Qualifications Department that its common shares did not comply with Nasdaq Listing Rule 5450(a)(1) for continued listing. The provided article text is truncated and does not specify the reason, any cure period, or the company’s next steps.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
MIST-0.65
More News
- Analysts react as Binance freezes assets after $6.3 billion security breach
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- PC chip plunge wipes out a quarter of Intel’s value
- Intel plunges on a major guidance miss. What went wrong — and how to proceed